Novavax, Inc. (NVAX): Price and Financial Metrics
Novavax, Inc. (NVAX)
Today's Latest Price: $13.05 USD
0.31 (2.43%)
Updated Mar 27 12:00am
Add NVAX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NVAX Stock Summary
- NVAX's price/sales ratio is 35.26; that's higher than the P/S ratio of 96.59% of US stocks.
- NVAX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 5.36% of US stocks.
- As for revenue growth, note that NVAX's revenue has grown -45.57% over the past 12 months; that beats the revenue growth of merely 3.95% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Novavax Inc, a group of peers worth examining would be BPMC, CTMX, ANAB, AGIO, and VBLT.
- Visit NVAX's SEC page to see the company's official filings. To visit the company's web site, go to www.novavax.com.
NVAX Daily Price Range
NVAX 52-Week Price Range
NVAX Stock Price Chart More Charts
NVAX Price/Volume Stats
| Current price | $13.05 | 52-week high | $17.71 |
| Prev. close | $12.74 | 52-week low | $3.54 |
| Day low | $12.15 | Volume | 8,245,600 |
| Day high | $13.45 | Avg. volume | 8,486,292 |
| 50-day MA | $9.08 | Dividend yield | N/A |
| 200-day MA | $5.95 | Market Cap | 672.44M |
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
Loading social stream, please wait...